Skip to main content

Ohio Venture Fund to Support Life Sciences

NEW YORK, April 9 (GenomeWeb News) - The State of Ohioannounced the formation of its first angel fund last week, which will make available $1.3 million to support "the commercialization of innovations in life sciences, information technology, physical sciences and novel service models in Ohio," according to a statement issued by the Columbus Venture Network.

Mike Bowers of the CVN confirmed that some investments from the fund would likely occur in genomic technology areas.

 

The fund, called the Ohio TechAngel Fund, has 50 private equity investors and is the largest angel fund in the upper Midwest, according to the statement.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.